Main Content start here
Main Layout
Report Description

Report Description

Global human insulin market was valued at USD26.91 billion in 2019 is expected to grow at a steady CAGR of 8.01% during the forecast period. Growing geriatric population, increasing diabetic patients, rising prevalence of obesity, and increasing demand for human insulin analogs are contributing to the surging demand for human insulin market, globally. Nowadays, diabetes is not only restricted to geriatric population, but it is also common among youth. Moreover, the technological advancements have eradicated human physical activities leading to obesity and diabetes disorders, which is directly influencing the growth of the market. Cost-effectiveness, reimbursement prices and strict regulatory requirements for approval of insulin can be considered major restraining factors for the Global Human Insulin Market.

The global human insulin market is segmented on the basis of indication, brand, route of administration, type, onset type, products, and region. Based on indication, market can be bifurcated into type-I diabetes and type-II diabetes. Type-I diabetes is likely to hold the largest market share of 84.60% until 2025 as human insulin is the most important treatment method for the people suffering from type-I diabetes. Based on brand, Lantus held the largest market share as it is one of the major selling products of Sanofi S.A. As of 2019, subcutaneous segment was the leading segment with a market share of 52.35% based on the route of administration as the insulin is absorbed more quickly with this method. Based on regional analysis, North America dominated the human insulin market in 2019 due to large pool of population suffering from diabetes and presence of leading companies in countries like US and Canada.

Leading players in the global human insulin market include Nektar Therapeutics, MannKind Corporation, Novo Nordisk A/S, Torrent Pharmaceuticals, Inc., Eli Lilly and Company, A-S Medication Solutions, RemedyRepack Inc., Sedico Co., Pharmaceutical Company, Sanofi S.A., Gan & Lee Pharmaceuticals, BioGenomics Ltd., Pfizer Inc., PerkinElmer, Merck & Co., Inc, Biocon Limited, Wockhardt Ltd., Ypsomed AG, Becton Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., among others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global human insulin market.
  • To classify and forecast global human insulin market based on indication, brand, route of administration, type, onset type, products and region.
  • To identify drivers and challenges for global human insulin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global human insulin market.
  • To conduct pricing analysis for global human insulin market.
  • To identify and analyze the profile of leading players operating in global human insulin market.


Click here to download the sample 

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global human insulin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to human insulin
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global human insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:
    • Type I Diabetes
    • Type II Diabetes
  • Market, By Brand:
    • Lantus
    • Humulin R
    • Novolin R
    • Humulin N
    • Exubera
    • Afrezza
    • Novolin N
  • Market, By Route of Administration:
    • Subcutaneous
    • Nasal
    • Intravenous
    • Transdermal
    • Oral
    • Others
  • Market, By Type:
    • Basal
    • Bolus
    • Pre-mixed
    • Biosimilar
    • Traditional
  • Market, By Onset Time:
    • Rapid acting
    • Short-acting
    • Intermediate acting
    • Long acting
    • Ultra-long acting
    • Pre-mixed
    • Inhaled
  • Market, By Products:
    • Insulin Pens
    • Insulin Pumps
    • Infusion System
    • Injection
  • Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Russia
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Singapore
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle east & Africa
      • Saudi Arabia
      • South Africa
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global human insulin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Human Insulin Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Human Insulin Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Indication (Type I Diabetes, Type II Diabetes)

6.2.2.     By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N)

6.2.3.     By Route of administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others)

6.2.4.     By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)

6.2.5.     By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)

6.2.6.     By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)

6.2.7.     By Company (2019)

6.2.8.     By Region

6.3.  Market Attractiveness Index

7.    North America Human Insulin Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Indication

7.2.2.     By Brand

7.2.3.     By Route of Administration

7.2.4.     By Type

7.2.5.     By Onset Time

7.2.6.     By Products

7.2.7.     By Country

7.3.  Market Attractiveness Index

7.4.  North America: Country Analysis

7.4.1.     United States Human Insulin Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Indication

7.4.1.2.2.             By Brand

7.4.1.2.3.             By Route of Administration

7.4.1.2.4.             By Type

7.4.1.2.5.             By Onset Time

7.4.1.2.6.             By Products

7.4.2.     Canada Human Insulin Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Indication

7.4.2.2.2.             By Brand

7.4.2.2.3.             By Route of Administration

7.4.2.2.4.             By Type

7.4.2.2.5.             By Onset Time

7.4.2.2.6.             By Products

7.4.3.     Mexico Human Insulin Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Indication

7.4.3.2.2.             By Brand

7.4.3.2.3.             By Route of Administration

7.4.3.2.4.             By Type

7.4.3.2.5.             By Onset Time

7.4.3.2.6.             By Products

8.    Europe Human Insulin Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Indication

8.2.2.     By Brand

8.2.3.     By Route of Administration

8.2.4.     By Type

8.2.5.     By Onset Time

8.2.6.     By Products

8.2.7.     By Country

8.3.  Market Attractiveness Index

8.4.  Europe: Country Analysis

8.4.1.     Germany Human Insulin Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Indication

8.4.1.2.2.             By Brand

8.4.1.2.3.             By Route of Administration

8.4.1.2.4.             By Type

8.4.1.2.5.             By Onset Time

8.4.1.2.6.             By Products

8.4.2.     United Kingdom Human Insulin Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Indication

8.4.2.2.2.             By Brand

8.4.2.2.3.             By Route of Administration

8.4.2.2.4.             By Type

8.4.2.2.5.             By Onset Time

8.4.2.2.6.             By Products

8.4.3.     France Human Insulin Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Indication

8.4.3.2.2.             By Brand

8.4.3.2.3.             By Route of Administration

8.4.3.2.4.             By Type

8.4.3.2.5.             By Onset Time

8.4.3.2.6.             By Products

8.4.4.     Italy Human Insulin Market Outlook

8.4.4.1.         Market Size & Forecast

8.4.4.1.1.             By Value

8.4.4.2.         Market Share & Forecast

8.4.4.2.1.             By Indication

8.4.4.2.2.             By Brand

8.4.4.2.3.             By Route of Administration

8.4.4.2.4.             By Type

8.4.4.2.5.             By Onset Time

8.4.4.2.6.             By Products

8.4.5.     Spain Human Insulin Market Outlook

8.4.5.1.         Market Size & Forecast

8.4.5.1.1.             By Value

8.4.5.2.         Market Share & Forecast

8.4.5.2.1.             By Indication

8.4.5.2.2.             By Brand

8.4.5.2.3.             By Route of Administration

8.4.5.2.4.             By Type

8.4.5.2.5.             By Onset Time

8.4.5.2.6.             By Products

8.4.6.     Russia Human Insulin Market Outlook

8.4.6.1.         Market Size & Forecast

8.4.6.1.1.             By Value

8.4.6.2.         Market Share & Forecast

8.4.6.2.1.             By Indication

8.4.6.2.2.             By Brand

8.4.6.2.3.             By Route of Administration

8.4.6.2.4.             By Type

8.4.6.2.5.             By Onset Time

8.4.6.2.6.             By Products

9.    Asia-Pacific Human Insulin Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Indication

9.2.2.     By Brand

9.2.3.     By Route of Administration

9.2.4.     By Type

9.2.5.     By Onset Time

9.2.6.     By Products

9.2.7.     By Country

9.3.  Market Attractiveness Index

9.4.  Asia-Pacific: Country Analysis

9.4.1.     China Human Insulin Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Indication

9.4.1.2.2.             By Brand

9.4.1.2.3.             By Route of Administration

9.4.1.2.4.             By Type

9.4.1.2.5.             By Onset Time

9.4.1.2.6.             By Products

9.4.2.     India Human Insulin Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Indication

9.4.2.2.2.             By Brand

9.4.2.2.3.             By Route of Administration

9.4.2.2.4.             By Type

9.4.2.2.5.             By Onset Time

9.4.2.2.6.             By Products

9.4.3.     Japan Human Insulin Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Indication

9.4.3.2.2.             By Brand

9.4.3.2.3.             By Route of Administration

9.4.3.2.4.             By Type

9.4.3.2.5.             By Onset Time

9.4.3.2.6.             By Products

9.4.4.     South Korea Human Insulin Market Outlook

9.4.4.1.         Market Size & Forecast

9.4.4.1.1.             By Value

9.4.4.2.         Market Share & Forecast

9.4.4.2.1.             By Indication

9.4.4.2.2.             By Brand

9.4.4.2.3.             By Route of Administration

9.4.4.2.4.             By Type

9.4.4.2.5.             By Onset Time

9.4.4.2.6.             By Products

9.4.5.     Australia Human Insulin Market Outlook

9.4.5.1.         Market Size & Forecast

9.4.5.1.1.             By Value

9.4.5.2.         Market Share & Forecast

9.4.5.2.1.             By Indication

9.4.5.2.2.             By Brand

9.4.5.2.3.             By Route of Administration

9.4.5.2.4.             By Type

9.4.5.2.5.             By Onset Time

9.4.5.2.6.             By Products

9.4.6.     Singapore Human Insulin Market Outlook

9.4.6.1.         Market Size & Forecast

9.4.6.1.1.             By Value

9.4.6.2.         Market Share & Forecast

9.4.6.2.1.             By Indication

9.4.6.2.2.             By Brand

9.4.6.2.3.             By Route of Administration

9.4.6.2.4.             By Type

9.4.6.2.5.             By Onset Time

9.4.6.2.6.             By Products

10.  South America Human Insulin Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Indication

10.2.2.  By Brand

10.2.3.  By Route of Administration

10.2.4.  By Type

10.2.5.  By Onset Time

10.2.6.  By Products

10.2.7.  By Country

10.3.              Market Attractiveness Index

10.4.              South America: Country Analysis

10.4.1.  Brazil Human Insulin Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Indication

10.4.1.2.2.           By Brand

10.4.1.2.3.           By Route of Administration

10.4.1.2.4.           By Type

10.4.1.2.5.           By Onset Time

10.4.1.2.6.           By Products

10.4.2.  Argentina Human Insulin Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Indication

10.4.2.2.2.           By Brand

10.4.2.2.3.           By Route of Administration

10.4.2.2.4.           By Type

10.4.2.2.5.           By Onset Time

10.4.2.2.6.           By Products

10.4.3.  Colombia Human Insulin Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Indication

10.4.3.2.2.           By Brand

10.4.3.2.3.           By Route of Administration

10.4.3.2.4.           By Type

10.4.3.2.5.           By Onset Time

10.4.3.2.6.           By Products

11.  Middle East and Africa Human Insulin Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Indication

11.2.2.  By Brand

11.2.3.  By Route of Administration

11.2.4.  By Type

11.2.5.  By Onset Time

11.2.6.  By Products

11.2.7.  By Country

11.3.              Market Attractiveness Index

11.4.              MEA: Country Analysis

11.4.1.  Saudi Arabia Human Insulin Market Outlook

11.4.1.1.      Market Size & Forecast

11.4.1.1.1.           By Value

11.4.1.2.      Market Share & Forecast

11.4.1.2.1.           By Indication

11.4.1.2.2.           By Brand

11.4.1.2.3.           By Route of Administration

11.4.1.2.4.           By Type

11.4.1.2.5.           By Onset Time

11.4.1.2.6.           By Products

11.4.2.  South Africa Human Insulin Market Outlook

11.4.2.1.      Market Size & Forecast

11.4.2.1.1.           By Value

11.4.2.2.      Market Share & Forecast

11.4.2.2.1.           By Indication

11.4.2.2.2.           By Brand

11.4.2.2.3.           By Route of Administration

11.4.2.2.4.           By Type

11.4.2.2.5.           By Onset Time

11.4.2.2.6.           By Products

11.4.3.  UAE Human Insulin Market Outlook

11.4.3.1.      Market Size & Forecast

11.4.3.1.1.           By Value

11.4.3.2.      Market Share & Forecast

11.4.3.2.1.           By Indication

11.4.3.2.2.           By Brand

11.4.3.2.3.           By Route of Administration

11.4.3.2.4.           By Type

11.4.3.2.5.           By Onset Time

11.4.3.2.6.           By Products

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  Novo Nordisk A/S

14.2.2.  Sanofi S.A.

14.2.3.  Eli Lilly and Company

14.2.4.  Biocon Limited

14.2.5.  Wockhardt Ltd

14.2.6.  Nektar Therapeutics

14.2.7.  Mannkind Corporation

14.2.8.  A-S Medication Solutions

14.2.9.  Remedyrepack Inc.

14.2.10.                Torrent Pharmaceuticals

14.2.11.                Sedico Co.

14.2.12.                Gan & Lee Pharmaceuticals

14.2.13.                BioGenomics Ltd

14.2.14.                Ypsomed AG

14.2.15.                Becton, Dickinson and Company

14.2.16.                B. Braun Melsungen AG

14.2.17.                Baxter International Inc.,

14.2.18.                Merck & Co., Inc

14.2.19.                PerkinElmer

14.2.20.                Pfizer Inc.

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables

Figure 1: Global Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 2: Global Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 3: Global Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 4: Global Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 5: Global Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 6: Global Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 7: Global Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 8: Global Human Insulin Market Share, By Company, By Value, 2019

Figure 9: Global Human Insulin Market Share, By Region, By Value, 2015-2025F

Figure 10: Global Human Insulin Market Share, By Region, By Value, 2015-2025F

Figure 11: Global Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)

Figure 12: Global Human Insulin Market Map, By Onset Time, Market Size (USD Billion) & Growth Rate (%)

Figure 13: Global Human Insulin Market Map, By Products, Market Size (USD Billion) & Growth Rate (%)

Figure 14: Global Human Insulin Market Map, By Region, Market Size (USD Billion) & Growth Rate (%)

Figure 15: North America Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 16: North America Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 17: North America Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 18: North America Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 19: North America Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 20: North America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 21: North America Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 22: North America Human Insulin Market Share, By Country, By Value, 2015-2025F

Figure 23: North America Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)

Figure 24: United States Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 25: Total Number of Diabetes patients in United States, By Value (Millions), 2019, 2030, 2045

Figure 26: United States Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 27: United States Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 28: United States Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 29:  United States Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 30: United States Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 31: United States Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 32: Canada Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 33: Total Number of Diabetes patients in Canada, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 34: Canada Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 35: Canada Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 36: Canada Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 37: Canada Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 38: Canada Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 39: Canada Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 40: Mexico Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 41: Total Number of Diabetes patients in Mexico, By Value (Millions), 2019, 2030, 2045

Figure 42: Mexico Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 43: Mexico Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 44: Mexico Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 45: Mexico Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 46: Mexico Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 47: Mexico Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 48: Europe Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 49: Europe Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 50: Europe Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 51: Europe Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 52: Europe Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 53: Europe Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 54: Europe Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 55: Europe Human Insulin Market Share, By Country, By Value, 2015-2025F

Figure 56: Europe Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)

Figure 57: Germany Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 58: Germany undiagnosed and diagnosed diabetes cases, 2019

Figure 59: Germany Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 60: Germany Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 61: Germany Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 62: Germany Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 63: Germany Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 64: Germany Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 65: United Kingdom Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 66: Different types of diabetes in United Kingdom, 2019

Figure 67: United Kingdom Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 68: United Kingdom Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 69: United Kingdom Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 70: United Kingdom Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 71: United Kingdom Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 72: United Kingdom Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 73: France Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 74: France Healthcare Spending, By Value (USD Per Capita), 2015-2019

Figure 75: France Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 76: France Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 77: France Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 78: France Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 79: France Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 80: France Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 81: Italy Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 82: Total Number of Diabetes patients in Italy, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 83: Italy Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 84: Italy Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 85: Italy Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 86: Italy Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 87: Italy Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 88: Italy Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 89: Spain Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 90: Total Number of Diabetes patients in Spain, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 91: Spain Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 92: Spain Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 93: Spain Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 94: Spain Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 95: Spain Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 96: Spain Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 97: Russia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 98: Total Number of Diabetes patients in Russia, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 99: Russia Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 100: Russia Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 101: Russia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 102: Russia Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 103: Russia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 104: Russia Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 105: Asia-Pacific Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 106: Asia-Pacific Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 107: Asia-Pacific Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 108: Asia-Pacific Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 109: Asia-Pacific Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 110: Asia-Pacific Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 111: Asia-Pacific Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 112: Asia-Pacific Human Insulin Market Share, By Country, By Value, 2015-2025F

Figure 113: Asia-Pacific Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)

Figure 114: China Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 115: Total Number of Diabetes patients in China, By Value (Millions), 2019, 2030, 2045

Figure 116: China Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 117: China Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 118: China Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 119: China Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 120: China Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 121: China Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 122: India Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 123: Total Number of Diabetes patients in India, By Value (Millions), 2019, 2030, 2045

Figure 124: India Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 125: India Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 126: India Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 127: India Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 128: India Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 129: India Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 130: Japan Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 131: Japan Total Health Expenditure as a share of GDP, 2015 - 2019

Figure 132: Japan Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 133: Japan Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 134: Japan Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 135: Japan Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 136: Japan Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 137: Japan Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 138: South Korea Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 139: Total Number of Diabetes patients in South Korea, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 140: South Korea Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 141: South Korea Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 142: South Korea Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 143: South Korea Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 144: South Korea Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 145: South Korea Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 146: Australia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 147: Total Number of Diabetes patients in Australia, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 148: Australia Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 149: Australia Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 150: Australia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 151: Australia Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 152: Australia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 153: Australia Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 154: Singapore Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 155: Total Number of Diabetes patients in Singapore, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 156: Singapore Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 157: Singapore Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 158: Singapore Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 159: Singapore Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 160: Singapore Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 161: Singapore Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 162: South America Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 163: South America Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 164: South America Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 165: South America Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 166: South America Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 167: South America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 168: South America Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 169: South America Human Insulin Market Share, By Country, By Value, 2015-2025F

Figure 170: South America Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)

Figure 171: Brazil Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 172: Total Number of Diabetes patients in Brazil, By Value (Millions), 2019, 2030, 2045

Figure 173: Brazil Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 174: Brazil Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 175: Brazil Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 176: Brazil Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 177: Brazil Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 178: Brazil Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 179: Argentina Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 180: Argentina Health Expenditure (% of GDP), 2015-2019

Figure 181: Argentina Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 182: Argentina Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 183: Argentina Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 184: Argentina Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 185: Argentina Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 186: Argentina Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 187: Colombia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 188: Total Number of Diabetes patients in Colombia, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 189: Colombia Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 190: Colombia Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 191: Colombia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 192: Colombia Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 193: Colombia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 194: Colombia Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 195: Middle East and Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 196: Middle East and Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 197: Middle East and Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 198: Middle East and Africa Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 199: Middle East and Africa Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 200: Middle East and Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 201: Middle East and Africa Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 202: Middle East and Africa Human Insulin Market Share, By Country, By Value, 2015-2025F

Figure 203: Middle East & Africa Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)

Figure 204: Saudi Arabia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 205: Total Number of Diabetes patients in Saudi Arabia, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 206: Saudi Arabia Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 207: Saudi Arabia Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 208: Saudi Arabia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 209: Saudi Arabia Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 210: Saudi Arabia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 211: Saudi Arabia Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 212: South Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 213: Total Number of Diabetes patients in South Africa, By Value (1000’s), 2010, 2019, 2030, 2045

Figure 214: South Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 215: South Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 216: South Africa Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 217: South Africa Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 218: South Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 219: South Africa Human Insulin Market Share, By Products, By Value, 2015-2025F

Figure 220: UAE Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F

Figure 221: UAE Health Expenditure (% of GDP), 2015-2019

Figure 222: UAE Human Insulin Market Share, By Indication, By Value, 2015-2025F

Figure 223: UAE Human Insulin Market Share, By Brand, By Value, 2015-2025F

Figure 224: UAE Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F

Figure 225: UAE Human Insulin Market Share, By Type, By Value, 2015-2025F

Figure 226: UAE Human Insulin Market Share, By Onset Time, By Value, 2015-2025F

Figure 227: UAE Human Insulin Market Share, By Products, By Value, 2015-2025F

Frequently asked questions

Frequently asked questions

Related Reports